Literature DB >> 1537230

Advances in the management of orbital fractures.

P N Nguyen1, P Sullivan.   

Abstract

Great progress has been made in both the basic science and the clinical knowledge base used in orbital reconstruction. With this, increasing complex orbital reconstructive problems are better managed. The diagnosis, treatment plan, and the actual reconstruction have evolved to a higher level. Several areas of progress are of note: the greater appreciation of the intimate relation between the bony orbit's shape and the position of the globe; application of computer technology in orbital injuries; effect of rigid fixation on autogenous and alloplastic graft; and the use of advanced biocompatible synthetic materials in orbital reconstruction. Although this progress has great impact on treatment of orbital injuries, there are many unanswered challenges in the treatment of the fragile frame of the window to the human soul.

Entities:  

Mesh:

Year:  1992        PMID: 1537230

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  4 in total

1.  Functional endoscopic sinus surgery: indications and complications in the ophthalmic field.

Authors:  Abdullah Al-Mujaini; Upender Wali; Mazin Alkhabori
Journal:  Oman Med J       Date:  2009-04

2.  Reconstruction of Orbital Floor Fractures with Titanium Micromesh: Our Experience.

Authors:  Chandrashekhar Chattopadhyay; Vikas Dev; Dinesh Pilania; Aditya Harsh
Journal:  J Maxillofac Oral Surg       Date:  2020-07-09

3.  The Role of Postoperative Imaging after Orbital Floor Fracture Repair.

Authors:  David Carpenter; Ronnie Shammas; Adam Honeybrook; C Scott Brown; Nikita Chapurin; Charles R Woodard
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2018-02-05

4.  Porous high-density polyethylene in facial reconstruction and revision rhinoplasty: a prospective cohort study.

Authors:  Shabahang Mohammadi; Shadi Ghourchian; Farzad Izadi; Ahmad Daneshi; Aslan Ahmadi
Journal:  Head Face Med       Date:  2012-05-29       Impact factor: 2.151

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.